Compare ProShares Ultra Silver ETF (AGQ) vs Alcon AG (ALC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ProShares Ultra Silver ETF vs Alcon AG — how do they compare? ProShares Ultra Silver ETF trades at $65.75, while Alcon AG trades at $66.64 (market cap $32.69B). The key difference: Alcon AG pays a 0.54% dividend while ProShares Ultra Silver ETF pays none, and Alcon AG is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.
| AGQ | ALC | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $400.47 | $92.22 |
52-Week Low | $48.15 | $62.02 |
Market Cap | — | $32.69B |
Enterprise Value | — | $36.28B |
Dividend Yield | — | 0.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Ultra Silver ETF
AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.
Read more on AGQ →About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →
